Ovarian cancer is the leading cause of death among patients bearing gynaecological cancers [1] 
reside in endosomes and lysosomes, where they accomplish the extensive or limited proteolysis of substrates at acid pH, thus contributing to cell protein turnover and homeostasis and activation or degradation of biologically active molecules [18] . Recently, these lysosomal cathepsins have been shown to actively participate in the cell death program following their translocation from lysosome into the cytosol [19] . For instance, CB has been shown to mediate caspase-independent cell death by microtubule stabilizing agent in lung cancer cells [20] and CD has been shown to mediate the caspase-dependent death pathway triggered by various DNA-damaging agents including etoposide [21, 22] . These findings underscore the importance of a lysosome-mitochondrion axis in the control of the death signal triggered by cytotoxic stress [23, 24] . Therefore, the function of these two organelles should also be considered when assessing the sensitivity or resistance towards apoptosis-inducing chemotherapy drugs in cancer cells. [4, 25] . We analysed the cytotoxic pathways of these drugs in two human ovarian cancer cell lines, namely A2780 and NIHOVCAR3 (OVCAR) , that have been reported to express normal or mutated p53, respectively [26, 27] . Both VP16 and taxol turned out to be toxic to A2780, not to 
In this respect, it is to note that resistance to cis-platinum in ovarian cancer cells was found associated with abnormalities of the lysosomal apparatus [9]. The present study was aimed at elucidating the potential role and the mechanism of action of CB, CL and CD in the cytotoxic response to etoposide (VePesid, VP16, SigmaAldrich Corp., St Louis, MO, USA) and Paclitaxel (Taxol, BristolMyers Squibb, New York, NY, USA), two drugs that have a welldocumented clinical efficacy against ovarian cancers that manifest resistance to platinum-based therapy

OVCAR cells. We found that chemosensitivity is associated with Bax-mediated permeabilization of lysosomes and mitochondria and that CD activity is mandatory for Bax activation and translocation onto lysosomes and mitochondria. Our data also indicate that Bax deficiency may result in the inability to permeabilize the lysosomes under toxic conditions, thus representing a primary defect that confers resistance towards chemotherapy drugs in cancer cells. We conclude that the CD-Bax cooperation is a critical determinant of chemosensitivity or chemoresistance in cancer cells.
Materials and methods
Chemicals were of analytical grade. Unless otherwise specified all reagents, including antibodies, were purchased from Sigma-Aldrich Corp. (St. Louis, MO, USA).
Cell culture and treatments
The human ovarian cancer cell lines A2780 and NIHOVCAR3 (OVCAR) 
Cathepsin D activity
To assay CD activity an aliquot of cell homogenate was incubated for 12 hrs at 37°C in a formate-acetate buffer (12.5 mM, pH 3.65 ) with 1 g aminomethylcoumarine-haemoglobin substrate in 50 l final volume [30] . (Fig. 3A) . Final cell density in CA074Me-treated A2780 cultures was reduced compared to that in control untreated or only Pst-treated counterparts, indicating that inhibition of CB and CL was itself cytotoxic to some extent to these cells (Fig. 3A) . OVCAR cells showed once again resistance to both chemotherapy drugs and also non-sensitive to the growth-inhibitory effect of CA074Me (Fig. 3A) . Fig. 4A and B 
Fluorescence microscope imaging
Fig. 2 Effect of VP16 on the expression and sub-cellular localization of Bax and bcl-2 in ovarian cancer cells. (A) The Western blotting shows that bcl-2 is highly expressed in OVCAR cells and very barely expressed in A2780 cells. VP16 greatly reduces (~50 %) the cellular content of bcl-2 in OVCAR cells, whereas it does not affect the expression of this protein in A2780 cells (see densitometry). (B) The Western blotting shows that Bax is highly expressed in A2780 and faintly detectable in OVCAR. Bax expression is not affected by VP16 (see densitometry). (C) Immnunolocalization of bcl-2 and
Cathepsin D activity is essential for Bax-mediated permeabilization of mitochondria and apoptosis
Bax has been shown to promote mitochondrial permeabilization and relocation of pro-apoptotic proteins from mitochondria into the cytosol [46]. In various paradigms of cytotoxic treatments conformational changes and oligomerization on mitochondrial membrane of Bax were shown to depend on CD [15, 28, 29]. We thus tested whether CD was implicated in Bax-dependent activation of the intrinsic death pathway in A2780 cells. Both Pst-mediated inhibition of CD activity and siRNA-mediated silencing of CD expression prevented the oligomerization of Bax and the mitochondria permeabilization induced by VP16 in A2780 (
Lysosome permeabilization, not cathepsin D expression, is the limiting factor for the activation of the intrinsic death pathway
Next, we investigated the molecular link between the proteolysis mediated by a lysosomal protease (i.e. CD) and the activation of a cytosolic protein (i.e. Bax). First, we considered the possibility that chemoresistance in OVCAR cells could arise from abnormally low expression of CD. Yet, when analysed by Western blotting, the basal expression level of CD was found much higher (~15 folds) in OVCAR than in A2780 cells (Fig. 5A). On treatment with VP16 the expression of CD did not change in OVCAR cells, whereas it greatly increased (~10 to 15 folds at 24 and 48 hrs, respectively)
in chemosensitive A2780 cells (Fig. 5A) . Based on previous findings [15, 28, 29, 47, 48] (Fig. 5C ).
, we hypothesized that Bax activation followed the cytosolic translocation of CD upon cytotoxic treatments. We thus looked at the compartmentalization of CD in the two cell lines under cytotoxic treatment. To better assess the possible relocation of CD from lysosomes into the cytosol, we labelled the
Fig. 3 Cathepsin D, not cathepsin B, mediates chemotherapy drug toxicity in A2780 cells. (A) A2780 cells and OVCAR cells plated on Petri dishes were exposed or not for 24 hrs to VP16 or taxol (Tax) in the absence or the presence of the CD inhibitor Pst or the CB inhibitor CA074Me (CA). At the end, cells were harvested and counted. The experiment was repeated four times in triplicate. Data are given as mean Ϯ S.D. In A2780 cells (top panel) both VP16 and taxol induced cell loss, which was prevented by Pst not by Ca074Me (compare final density at day 1 in treated versus initial density at d0 in cultures; note that Pst abrogated cell death by the chemotherapy drugs though it not completely rescued the cells from a growth block). Inhibition of CB and CL, on the other hand, did not protect from drug toxicity and, on itself, caused some cell loss in A2780 culture. In OVCAR cells (bottom panel) VP16 and taxol were not toxic and no effect were exerted by the cathepsin inhibitors either alone or in combination with the chemotherapy drugs. (B) A2780 cells plated on Petri dishes were transfected with a control duplex RNA (sham) or a CD specific siRNA and 24 hrs later incubated in fresh medium for further 24 hrs in the absence or in the presence of VP16 or taxol (Tax). Prior to start the treatment, CD activity was assayed in parallel homogenates to ascertain down-regulation of CD in siRNA-transfected cultures (upper panel). At the end of the incubation, cell survival was estimated counting the adherent trypan-blue excluding cells (lower panel
Bax mediates the permeabilization of lysosomes induced by VP16 in chemosensitive A2780 cells
How lysosomal membrane is permeabilized, thus allowing cathepsins to escape into the cytosol, following the treatment with a cytotoxic drug remains elusive. It has been proposed that members
Fig. 4 Cathepsin D triggers Bax-mediated permeabilization of mitochondria and TUNEL-positive cell death in response to VP16. A2780 cells were let adhere on coverslips and pre-incubated for 16 hrs with Pst (A) or sham-transfected or transfected with a CD-specific siRNA (B). The cells were then treated or not with VP16 for 24 hrs and thereafter processed for mitotracker staining and Bax immunofluorescence. Both genetic down-regulation and pharmacological inhibition of CD prevented the activation and oligomerization of Bax onto mitochondria induced by VP16. (C) A2780 cells adherent on coverslips were exposed for 24 hrs to VP16 and then stained with the TUNEL technique that demonstrated the presence of nicked DNA in apoptotic cells. Images are representative of three separate experiments. Selected fields are shown. Note that only cells still adherent on coverslips were labelled (detached cells were discarded).
of the bcl-2 family could also affect the stabilization of lysosomal membranes [50] . Consistently, Bax has been shown to insert onto lysosomal membranes in staurosporine-treated fibroblasts [51] . We found that on treatment with VP16, Bax in fact was activated and formed macro-aggregates positive also for Lamp1 in A2780 cells, but not in OVCAR cells (Fig. 6A) (Fig. 6B) . Under such 
Fig. 5 Effects of VP16 on the expression and localization of cathepsin D and on lysosome integrity. (A) Western blotting analysis of CD expression in A2780 and OVCAR cells. The precursor (P) and the mature double-chain form resident in lysosomes (M, only the large chain is visible on gel) are expressed at different ratio in the two ovarian cancer cell lines. The chemoresistant OVCAR cell line basally expresses higher level of both proCD and mature CD than the chemosensitive A2780 cell line. VP16 greatly increases the cellular content of mature CD in A2780 cells, whereas it has no effect on CD expression in OVCAR cells (densitometry of the M polypeptide normalized against actin is shown). (B) Cells adherent on coverslips were treated for 24 hrs with VP16 and then processed for immunofluorescence staining of CD (green fluorescence) and Lamp1 (red fluorescence). The images show a diffuse CD staining indicative of cytosolic localization in VP16-treated A2780 cells (lysosomes are identified as Lamp1-positive vesicles), whereas in control untreated cells CD staining appears as definite yellow spots that denote its localization within Lamp1-positive vesicles. In OVCAR cells, either control or VP16-treated, CD shows a granular-like staining and fully co-localizes with Lamp1. (C) Cells adherent on coverslips and exposed or not to VP16 were stained with acridine orange (AO) and observed under the fluorescence microscope. Red staining is indicative of segregation of the fluorochrome within acid compartments (i.e. endosomes and lysosomes), whereas green fluorescence is indicative of cytosolic localization of the fluorochrome. The images demonstrate that in A2780 cells, not in OVCAR cells, VP16 induces the cytosolic relocation of AO. The results shown in (A), (B) and (C) are representative of at least three independent experiments.
Fig. 6 Bax is essential for VP16-induced permeabilization of lysosomal in A2780 cells. (A) Cells adherent on coverslips were treated for 24 hrs with VP16 and then processed for immunofluorescence staining of Bax (green fluorescence) and Lamp1 (red fluorescence). The images show a diffuse and faintly detectable Bax staining in control A2780 cells, as well as in control and VP16-treated OVCAR cells. The granular-like staining of Lamp1 identifies the lysosomes. Of note, in VP16-treated A2780 cells Bax appears as intense yellow spots indicative of conformational activation and aggregation on Lamp1-positive vesicles. (B) A2780 cells plated on Petri dishes were sham-or Bax-siRNA-transfected or not transfected (NT) and after 24 hrs exposed or not for further 24 hrs to VP16. The Western blotting of Bax confirms that: (i) VP16 induced the expression and accumulation of Bax; (ii) siRNA transfection efficiently silenced the expression of Bax (see densitometry). (C) A2780 cells adherent on coverslips were sham-or
Cathepsin D triggers the translocation of Bax onto lysosome membrane upon VP16 treatment
Since Bax activation and oligomerization on mitochondria was proven to depend on CD activity (see Fig. 4A and B and [28, 29] 
Discussion
Resistance to chemotherapy drugs is the principal factor limiting long-term treatment success in ovarian cancer management [4] . The molecular dissection of the pathways activated by cytotoxic drugs may help to identify the molecular mechanisms implicated in multidrug resistance, and can positively reflect on designing new therapeutic approaches to circumvent this phenomenon [5] . Among the factors that concur to the resistant phenotype in cancer cells are the overexpression of ATP-dependent transporters that actively extrude the cytotoxic drugs [52] and defective activation of the apoptotic pathway due to altered expression of key regulators or executioners [12, 21, 31, 34] Fig. 4 
(B). Parallel coverslips were pre-incubated or not with Pst (A). The cells were then exposed or not for 24 hrs to VP16 and thereafter processed for immunofluorescence staining of Bax (green fluorescence) and Lamp1 (red fluorescence). Bax staining is faintly detectable and diffused in the cytoplasm of untreated cells, whereas it appears as intense yellow spots, indicative of co-localization with Lamp1 (arrows), in sham-transfected and in Pst-non-preincubated A2780 cells exposed to VP16. Both siRNA-mediated downregulation or Pst-mediated inhibition of CD prevented the Bax translocation onto lysosomes in VP16-treated cells, as demonstrated by the lack of co-localization with Lamp1. In these cells Bax staining is faintly detectable and diffused in the cytoplasm as in control untreated cells.
cancers [31, 37, 53] . 
